Last reviewed · How we verify

NCT04085731

Driver-guided Ablation of Persistent Atrial Fibrillatiom

Status unknown Last updated 2 October 2023
What this trial tests

trial testing Catheter ablation in Persistent Atrial Fibrillation in 181 participants. Status unknown.

Timeline
21 September 2019
Primary endpoint
28 September 2023
30 December 2023

Quick facts

Lead sponsorIRCCS Policlinico S. Donato
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment181
Start date21 September 2019
Primary completion28 September 2023
Estimated completion30 December 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Policlinico S. Donato

Who can join

Adults 18 to 85, any sex, with Persistent Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, single-center, study. A targeted number of 181patients with persistent AF will be included according to pre-defined criteria. The ablation procedure consists on the identification of the arrhythmic substrate using a novel integrated mapping technique. We hypothesize that such approach may potentially lead to a mechanisms-targeted ablation strategy of persistent AF.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Catheter ablation

Trials testing the same drug.

Other recruiting trials for Persistent Atrial Fibrillation

Currently open trials in the same condition.

Other IRCCS Policlinico S. Donato trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04085731.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing